We are exploring whether certain psychotropic medications can help reduce agitation in dementia patients who haven't responded to standard treatments. The study also examines potential side effects and personalized treatment methods.
Health conditions and diseases that the clinical trial is designed to study and treat.
Agitated behavior refers to a state of increased restlessness or irritability, often characterized by excessive movement, anxiety, or emotional distress. It can be a response to various underlying conditions, including mental health disorders.
Dementia is a general term for a decline in cognitive function, affecting memory, thinking, and social abilities severely enough to interfere with daily life. Alzheimer's disease is the most common cause of dementia.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.